Larvol Delta - First-Patient-Dosed-in-Aptevos-Ongoing-RAINIER-Trial-Achieves-90-Reduction-in-Leukemic-Blasts-Within-the-First-30-Days-of-Treatment-Continues-Overall-Efcacy-Trend-Seen-in-Prior-Mipletamig-AML-Studies

mipletamig (APVO436) - Aptevo Therap

https://www.accesswire.com/944837/first-patient-dosed-in-aptevos-ongoing-rainier-trial-achieves-90-reduction-in-leukemic-blasts-within-the-first-30-days-of-treatment-continues-overall-efficacy-trend-seen-in-prior-mipletamig-aml-studies

Nov 20, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next